Nicotinamide riboside and pterostilbene reduces frequency and severity of undesirable symptoms of the menopause transition: an open-label, pilot clinical trial.
Abstract
Nicotinamide riboside and pterostilbene reduces frequency and severity of undesirable symptoms of the menopause transition: an open-label, pilot clinical trial.
Authors: Holmes HE, Srivastava K, Scalici JM, Dhuguru J, Shea AE, Migaud ME, D…